Burkitt Lymphoma

Showing 26 - 50 of 56

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Leukemia, Acute Myeloid Leukemia, MDS Trial in Philadelphia (CliniMACS Cell Processing System for TCRaß + T Cell and

Recruiting
  • Acute Leukemia
  • +7 more
  • CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Mar 21, 2022

Burkitt Lymphoma, Retinoblastoma, Diffuse Large B-cell Lymphoma Trial in Mwanza (mNavigator)

Active, not recruiting
  • Burkitt Lymphoma
  • +2 more
  • mNavigator
  • Mwanza, Lake Zone, Tanzania
    Bugando Medical Centre
Mar 7, 2022

Burkitt Lymphoma, KSHV-associated Multicentric Castleman Disease, DLBCL Trial in Kampala (Rituximab and Hyaluronidase Human,

Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Rituximab and Hyaluronidase Human
  • +8 more
  • Kampala, Uganda
    UCI-Fred Hutch Cancer Centre
Mar 9, 2022

High-grade B-cell Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell Trial in Busan, Seoul (Sepantronium Bromide)

Not yet recruiting
  • High-grade B-cell Lymphoma
  • +8 more
  • Sepantronium Bromide
  • Busan, Korea, Republic of
  • +5 more
Feb 27, 2022

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • +12 more
    • Bedford, Bedfordshire, United Kingdom
    • +8 more
    Feb 22, 2022

    Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States

    Completed
    • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
    • +5 more
    • Hematopoietic Umbilical Cord Blood Stem Cell Transplantation
    • GVHD prophylaxis
    • Duarte, California
    • +15 more
    Nov 2, 2021

    B-cell Lymphoma, Burkitt Lymphoma, Diffuse Large B Cell Lymphoma Trial in Valhalla (Polatuzumab vedotin)

    Recruiting
    • B-cell Lymphoma
    • +8 more
    • Polatuzumab vedotin
    • Valhalla, New York
      New York Medical Center
    Oct 29, 2021

    Children With Burkitt's Lymphoma

    Recruiting
    • Burkitt Lymphoma
    • OBSERVATIONAL
    • Ouagadougou, Burkina Faso
    • +6 more
    Oct 26, 2021

    Diffuse Large B Cell Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Wuhan (BTK inhibitor+ Fludarabine +

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • +4 more
    • BTK inhibitor+ Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
    • Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
    • Wuhan, Hubei, China
      Union Hospital, Huazhong University of Science and Technology
    Oct 13, 2021

    Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, Burkitt Leukemia Trial in Houston (drug,

    Completed
    • Acute Lymphoblastic Leukemia
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 6, 2021

    Burkitt Lymphoma, CD20-Positive Neoplastic Cells Present, DLBCL Trial in Seattle (biological, procedure, drug, radiation, other)

    Terminated
    • Burkitt Lymphoma
    • +6 more
    • Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein
    • +11 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 30, 2020

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Burkitt Lymphoma Trial in Cincinnati (CPX-351)

    Completed
    • Acute Myeloid Leukemia
    • +7 more
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Nov 6, 2020

    Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies Trial in Minneapolis (Infusion of Treg)

    Terminated
    • Acute Lymphoblastic Leukemia
    • +17 more
    • Infusion of Treg
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Sep 8, 2020

    B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

    Completed
    • B-cell Chronic Lymphocytic Leukemia
    • +9 more
    • Stanford, California
    • +15 more
    May 14, 2020

    Lymphoma, Large B-Cell, Diffuse, Burkitt Lymphoma Trial (Gallium citrate)

    Withdrawn
    • Lymphoma, Large B-Cell, Diffuse
    • Burkitt Lymphoma
    • Gallium citrate
    • (no location specified)
    Oct 8, 2019

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +77 more
    • fludarabine phosphate
    • +8 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Sep 16, 2019

    Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States

    Completed
    • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
    • +5 more
    • Haploidentical Bone Marrow Transplantation
    • GVHD prophylaxis
    • Duarte, California
    • +16 more
    Nov 28, 2017

    Lymphoid Malignancies (New or Relapsed), Acute Lymphoblastic Leukemia, Burkitt Lymphoma Trial in Philadelphia (Hyper-CVAD,

    Completed
    • Lymphoid Malignancies (New or Relapsed)
    • +5 more
    • Philadelphia, Pennsylvania
    • +1 more
    Nov 10, 2017

    Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Burkitt Lymphoma Trial in Duarte, Chapel Hills (Alisertib)

    Terminated
    • Diffuse Large B-cell Lymphoma
    • +2 more
    • Duarte, California
    • +1 more
    Nov 16, 2017

    Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in United States (SGN-CD19A)

    Completed
    • Burkitt Lymphoma
    • +4 more
    • Birmingham, Alabama
    • +5 more
    Oct 17, 2017

    Acute Lymphoblastic Leukemia, Burkitt Lymphoma Trial (CD19 CAR and PD-1 knock out engineered T-cells, CD19 CAR T-cells)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • Burkitt Lymphoma
    • CD19 CAR and PD-1 knock out engineered T-cells
    • CD19 CAR T-cells
    • (no location specified)
    Sep 26, 2017

    Burkitt Lymphoma, Precursor B-cell Lymphoblastic Leukemia-Lymphoma Trial in United States (SGN-CD19A)

    Completed
    • Burkitt Lymphoma
    • Precursor B-cell Lymphoblastic Leukemia-Lymphoma
    • Birmingham, Alabama
    • +12 more
    Jun 29, 2017

    Burkitt Lymphoma, B-ALL Trial in Italy (Chemotherapy-Rituximab combination)

    Completed
    • Burkitt Lymphoma
    • B-ALL
    • Chemotherapy-Rituximab combination
    • Bolzano, (bz), Italy
    • +11 more
    Sep 15, 2014

    Non-Hodgkin's Lymphoma, Burkitt Lymphoma, Primary Effusion Lymphomas Trial in Los Angeles (Pegylated Liposomal Doxorubicin

    Terminated
    • Non-Hodgkin's Lymphoma
    • +2 more
    • Pegylated Liposomal Doxorubicin (Doxil) and Rituximab
    • Los Angeles, California
      USC/Norris Comprehensive Cancer Center and Hospital
    May 20, 2014